Christopher E. Jensen

598 total citations
34 papers, 298 citations indexed

About

Christopher E. Jensen is a scholar working on Hematology, Oncology and Genetics. According to data from OpenAlex, Christopher E. Jensen has authored 34 papers receiving a total of 298 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Hematology, 9 papers in Oncology and 8 papers in Genetics. Recurrent topics in Christopher E. Jensen's work include Acute Myeloid Leukemia Research (5 papers), Multiple Myeloma Research and Treatments (5 papers) and Chronic Lymphocytic Leukemia Research (4 papers). Christopher E. Jensen is often cited by papers focused on Acute Myeloid Leukemia Research (5 papers), Multiple Myeloma Research and Treatments (5 papers) and Chronic Lymphocytic Leukemia Research (4 papers). Christopher E. Jensen collaborates with scholars based in United States, Colombia and Denmark. Christopher E. Jensen's co-authors include Arturo Loaiza‐Bonilla, Gladys Block, S P H Mandel, Patricia Wakimoto, Stuti G. Shroff, Jennifer J.D. Morrissette, Michael P. Randall, Susan R. Weiss, Sascha A. Tuchman and Samuel Wilson and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Scientific Reports.

In The Last Decade

Christopher E. Jensen

26 papers receiving 290 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Christopher E. Jensen United States	8	107	70	50	49	41	34	298
Basma Merhi United States	9	64 0.6×	60 0.9×	41 0.8×	43 0.9×	18 0.4×	26	309
Waseem Khaliq United States	11	113 1.1×	43 0.6×	52 1.0×	41 0.8×	18 0.4×	51	322
Silvia Mura Italy	12	75 0.7×	173 2.5×	65 1.3×	49 1.0×	37 0.9×	17	475
Sandrine Kerbrat France	9	53 0.5×	23 0.3×	48 1.0×	62 1.3×	19 0.5×	27	349
In Sook Sohn South Korea	11	68 0.6×	88 1.3×	44 0.9×	30 0.6×	13 0.3×	67	435
En Cheng United States	11	222 2.1×	80 1.1×	43 0.9×	71 1.4×	28 0.7×	30	420
Avinash Pandey India	10	95 0.9×	38 0.5×	13 0.3×	83 1.7×	27 0.7×	38	289
Debra J. Szeluga United States	11	217 2.0×	29 0.4×	79 1.6×	79 1.6×	42 1.0×	22	430
Gholamreza Bahoush Iran	10	52 0.5×	65 0.9×	44 0.9×	37 0.8×	14 0.3×	40	273
Kentaro Masuhiro Japan	9	134 1.3×	39 0.6×	36 0.7×	80 1.6×	15 0.4×	22	363

Countries citing papers authored by Christopher E. Jensen

Since Specialization

Citations

This map shows the geographic impact of Christopher E. Jensen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher E. Jensen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher E. Jensen more than expected).

Fields of papers citing papers by Christopher E. Jensen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher E. Jensen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher E. Jensen. The network helps show where Christopher E. Jensen may publish in the future.

Co-authorship network of co-authors of Christopher E. Jensen

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher E. Jensen. A scholar is included among the top collaborators of Christopher E. Jensen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher E. Jensen. Christopher E. Jensen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Roeker, Lindsey E., John M. Burke, Joanna Rhodes, et al.. (2025). Real-World Effectiveness of Frontline Treatments Among Patients with Chronic Lymphocytic Leukemia: Results from ConcertAI. Cancers. 17(5). 799–799. 1 indexed citations

Oldan, Jorge D., Christopher E. Jensen, Deborah M. Stephens, et al.. (2025). Comparison of standardized uptake value and standardized uptake lean body mass metrics in 18F-fluorodeoxyglucose positron emission tomography for assessing transformation in chronic lymphocytic leukemia and follicular lymphoma. Quantitative Imaging in Medicine and Surgery. 15(8). 6616–6626.

Zhou, Xi, Christopher D. Baggett, Sascha A. Tuchman, et al.. (2024). Second Line Therapy in Multiple Myeloma: A SEER Medicare Analysis. Clinical Lymphoma Myeloma & Leukemia. 24(9). 611–620. 1 indexed citations

Lund, Jennifer L., Arjun Gupta, Antonia V. Bennett, et al.. (2024). Home Time Among Older Adults With Acute Myeloid Leukemia Following Chemotherapy. Carolina Digital Repository (University of North Carolina at Chapel Hill). 1 indexed citations

Jensen, Christopher E., Tzy‐Mey Kuo, Christopher D. Baggett, et al.. (2024). Functional Status Associations With Treatment Receipt and Outcomes Among Older Adults Newly Diagnosed With Multiple Myeloma. JCO Clinical Cancer Informatics. 8(8). e2300214–e2300214.

Stephens, Deborah M., Chris Stewart, Catherine C. Coombs, et al.. (2024). Feasibility of Discontinuation of Bruton's Tyrosine Kinase Inhibitors in Patients with Chronic Lymphocytic Leukemia: A Patient Survey. Blood. 144(Supplement 1). 7743–7743.

Brown, Siobhan P., Anton Ilich, Amy Sarah Ginsburg, et al.. (2024). Fewer severe infections with tranexamic acid in patients with hematologic malignancies. Research and Practice in Thrombosis and Haemostasis. 8(2). 102358–102358.

Jensen, Christopher E., F. Işık Karahanoğlu, Xuemei Cai, et al.. (2024). Associations between wearable device metrics and performance status in adult patients with cancer.. JCO Oncology Practice. 20(10_suppl). 427–427.

Jensen, Christopher E., Allison M. Deal, Kirsten A. Nyrop, et al.. (2023). Geriatric assessment-guided interventions for older adults with multiple myeloma: A feasibility and acceptability study. Journal of Geriatric Oncology. 15(2). 101680–101680. 3 indexed citations

10.

Heiling, Hillary, Allison M. Deal, Christopher E. Jensen, et al.. (2022). Longitudinal Analysis of Patient-Reported Cognitive Function in Multiple Myeloma. Clinical Lymphoma Myeloma & Leukemia. 22(12). 920–927. 6 indexed citations

11.

Jensen, Christopher E., Kirsten A. Nyrop, Allison M. Deal, et al.. (2022). Physical Function, Psychosocial Status, and Symptom Burden Among Adults with Plasma Cell Disorders and Associations with Quality of Life. The Oncologist. 27(8). 694–702. 6 indexed citations

12.

Jensen, Christopher E., Nathan D. Montgomery, Jonathan Galeotti, Matthew C. Foster, & Joshua F. Zeidner. (2022). Clinical and molecular features of FLT3 juxtamembrane domain missense mutations in acute myeloid leukaemia. Journal of Cellular and Molecular Medicine. 26(24). 6079–6082. 2 indexed citations

13.

Jensen, Christopher E.. (2022). The GPIIb-IIIa defect of platelets in Glanzmann thrombasthenia. Haematologica. 108(4). 937–938. 7 indexed citations

14.

Jensen, Christopher E., Mirnela Byku, Gerald A. Hladik, et al.. (2022). Supportive Care and Symptom Management for Patients With Immunoglobulin Light Chain (AL) Amyloidosis. Frontiers in Oncology. 12. 907584–907584. 7 indexed citations

15.

Jensen, Christopher E., Kirsten A. Nyrop, Allison M. Deal, et al.. (2021). Geriatric-assessment-identified functional deficits among adults with multiple myeloma with normal performance status. Journal of Geriatric Oncology. 13(2). 182–189. 18 indexed citations

16.

Wei, Trent L., et al.. (2019). The Triage of Older Adults with Physiologic Markers of Serious Injury Using a State-Wide Prehospital Plan. Prehospital and Disaster Medicine. 34(5). 497–505. 10 indexed citations

17.

Jensen, Christopher E., et al.. (2018). Differences in overall survival and mutation prevalence between right- and left-sided colorectal adenocarcinoma. Journal of Gastrointestinal Oncology. 9(3). 778–784. 13 indexed citations

18.

Loaiza‐Bonilla, Arturo, et al.. (2018). A KRAS wild type mutational status confers a survival advantage in pancreatic ductal adenocarcinoma. Journal of Gastrointestinal Oncology. 9(1). 1–10. 44 indexed citations

19.

Loaiza‐Bonilla, Arturo, Christopher E. Jensen, Stuti G. Shroff, et al.. (2016). KDR Mutation as a Novel Predictive Biomarker of Exceptional Response to Regorafenib in Metastatic Colorectal Cancer. Cureus. 8(2). e478–e478. 25 indexed citations

20.

Block, Gladys, et al.. (2006). Peer Reviewed: Validation of a Food Frequency Questionnaire for Hispanics. Preventing Chronic Disease. 3(3). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact